Skip to main content
letter
. 2024 Mar 27;37(3):276–278. doi: 10.37201/req/149.2023

Table 1.

C. striatum infections treated with dalbavancin

Author [reference], year Number of cases Type of infection Corynebacterium species Previous therapies Dalbavancin indication Dalbavancin dose regimen Adverse effects Outcome
Molina-Collada [6], 2017 n=1 Septic native knee arthritis C. striatum Linezolid
Teicoplanin
Failure (n=1) 1500 mg (one dose) None (n=1) Cure (n=1)
Navarro-Jiménez [7], 2022 n=7 Diabetic foot osteomyelitis C. striatum Cotrimoxazole, tedizolid, ciprofloxacin, linezolid, amoxicillin-clavulanate, clindamycin Failure (n=3)
Side effects (n=3)
Failure and Side effects (n=1)
1500 mg (one dose) to 1500 mg weekly for 5 weeks None (n=5)
Nausea (n=1)
Cure (n=6)
Failure (n=1)
Mansoor [8], 2023 n=6 LVAD C. striatum Vancomycin, tedizolid, daptomycin, levofloxacin, omadacycline Convenience (n=5)
Side effects (n=1)
1500 mg every two weeks None (n=6) Cure (n=3)
Heart transplantation (n=1)
Failure (n=1)
LVAD thrombosis (n=1)
Soderqüist [9],2023 n=1 PJI C. striatum Vancomycin, linezolid, daptomycin Side effects (n=1) 1500 mg every week for 12 weeks None (n=1) Cure (n=1)
Camara [present case], 2023 n=1 PJI C. striatum vancomycin Convenience (n=1) 1000 mg (load dose) and 500 mg weekly for 6 weeks. None (n=1) Cure (n=1)

LVAD: Left Ventricular Assist Device; PJI: Periprosthetic joint infection.